Maze Therapeutics, Inc. (MAZE)
Across 6 earnings reports since Mar 31, 2025, Maze Therapeutics, Inc. (MAZE) has a clear post-earnings pattern. It moves ±8.35% on average after reporting and finishes higher 33.3% of the time. Its largest post-earnings gain was +4.66% (May 12, 2026) and its largest decline was -35.24% (Mar 25, 2026).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
6
Avg Abs. Movement
±8.35%
Positive %
33.3%
Negative %
66.7%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | ☽ POST | $25.46 | $26.12 | $25.74 | 20,288 | +4.66% | open_in_new |
| Mar 25, 2026 | ☀ PRE | $40.00 | $41.00 | $31.73 | 8,232,100 | -35.24% | open_in_new |
| Nov 06, 2025 | ☽ POST | $29.99 | $30.30 | $29.63 | 276,100 | -3.48% | open_in_new |
| Aug 12, 2025 | ☽ POST | $13.50 | $13.85 | $13.74 | 99,700 | -1.02% | open_in_new |
| May 14, 2025 | ☽ POST | $9.85 | $10.08 | $9.06 | 106,900 | +2.1% | open_in_new |
| Mar 31, 2025 | ☀ PRE | $10.91 | $11.94 | $11.01 | 285,600 | -3.59% | open_in_new |
Earnings Count
6
Total earnings in dataset
Avg Abs. Movement
±8.35%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 8-K | 20260610 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
Frequently asked about MAZE earnings
How much does MAZE stock move after earnings? expand_more
Over 6 reports, MAZE has moved an average of ±8.35% the session after earnings, closing higher 33.3% of the time.
What was MAZE's biggest post-earnings move? expand_more
MAZE's largest post-earnings gain on record was +4.66% on May 12, 2026, and its largest decline was -35.24% on Mar 25, 2026.
Where can I find Maze Therapeutics, Inc.'s SEC filings? expand_more
All of Maze Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right